Kevin Feeley
CIK: 0001944119
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GeneDx Holdings Corp.
Discretionary Trading P&L
Holdings
Transaction History (146 total)
- Sep 16, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct541 shares at avg. $96.90$52K - Sep 16, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct52 shares at avg. $95.41$5K - Sep 16, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct1.5K shares at avg. $98.27$144K - Sep 16, 2026WGS
GeneDx Holdings Corp.
Exercise(M)Direct7.2K shares- - Sep 16, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct586 shares at avg. $94.26$55K - Sep 16, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct1.1K shares at avg. $99.00$107K - Sep 9, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct1.3K shares at avg. $84.22$108K - Sep 9, 2026WGS
GeneDx Holdings Corp.
Exercise(M)Direct2.5K shares- - Sep 1, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct372 shares at avg. $83.84$31K - Sep 1, 2026WGS
GeneDx Holdings Corp.
Exercise(M)Direct717 shares- - Jun 16, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct863 shares at avg. $61.50$53K - Jun 16, 2026WGS
GeneDx Holdings Corp.
Exercise(M)Direct7.2K shares- - Jun 16, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct760 shares at avg. $59.75$45K - Jun 16, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct2.1K shares at avg. $60.83$128K - Jun 9, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct1.3K shares at avg. $53.77$68K - Jun 9, 2026WGS
GeneDx Holdings Corp.
Exercise(M)Direct2.5K shares- - Jun 1, 2026WGS
GeneDx Holdings Corp.
Exercise(M)Direct717 shares- - Jun 1, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct369 shares at avg. $51.74$19K - Apr 29, 2026WGS
GeneDx Holdings Corp.
Exercise(M)Direct754 shares- - Apr 29, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct392 shares at avg. $65.19$26K - Mar 26, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct1.9K shares at avg. $65.21$121K - Mar 26, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct2.5K shares at avg. $63.28$159K - Mar 26, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct995 shares at avg. $64.60$64K - Mar 26, 2026WGS
GeneDx Holdings Corp.
Exercise(M)Direct16.3K shares- - Mar 26, 2026WGS
GeneDx Holdings Corp.
Sale(S)Direct2.5K shares at avg. $61.29$152K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 541 | $96.90 | $52,423 | Direct |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 52 | $95.41 | $4,961 | Direct |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 1,470 | $98.27 | $144,457 | Direct |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | Exercise(M) | 7,197 | - | $0 | Direct |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 586 | $94.26 | $55,235 | Direct |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 1,079 | $99.00 | $106,816 | Direct |
| Sep 9, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 1,285 | $84.22 | $108,220 | Direct |
| Sep 9, 2026 | WGS GeneDx Holdings Corp. | Exercise(M) | 2,462 | - | $0 | Direct |
| Sep 1, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 372 | $83.84 | $31,188 | Direct |
| Sep 1, 2026 | WGS GeneDx Holdings Corp. | Exercise(M) | 717 | - | $0 | Direct |
| Jun 16, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 863 | $61.50 | $53,078 | Direct |
| Jun 16, 2026 | WGS GeneDx Holdings Corp. | Exercise(M) | 7,197 | - | $0 | Direct |
| Jun 16, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 760 | $59.75 | $45,413 | Direct |
| Jun 16, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 2,106 | $60.83 | $128,106 | Direct |
| Jun 9, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 1,266 | $53.77 | $68,073 | Direct |
| Jun 9, 2026 | WGS GeneDx Holdings Corp. | Exercise(M) | 2,462 | - | $0 | Direct |
| Jun 1, 2026 | WGS GeneDx Holdings Corp. | Exercise(M) | 717 | - | $0 | Direct |
| Jun 1, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 369 | $51.74 | $19,092 | Direct |
| Apr 29, 2026 | WGS GeneDx Holdings Corp. | Exercise(M) | 754 | - | $0 | Direct |
| Apr 29, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 392 | $65.19 | $25,555 | Direct |
| Mar 26, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 1,857 | $65.21 | $121,103 | Direct |
| Mar 26, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 2,520 | $63.28 | $159,463 | Direct |
| Mar 26, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 995 | $64.60 | $64,276 | Direct |
| Mar 26, 2026 | WGS GeneDx Holdings Corp. | Exercise(M) | 16,250 | - | $0 | Direct |
| Mar 26, 2026 | WGS GeneDx Holdings Corp. | Sale(S) | 2,485 | $61.29 | $152,308 | Direct |
1-25 of 146 transactions
About Feeley Kevin
Feeley Kevin (SEC CIK 0001944119) files insider reports with the SEC as CHIEF FINANCIAL OFFICER of GeneDx Holdings Corp. (WGS).
Signal8 holds 47 ownership filings by Feeley Kevin, all Form 4s, filed between Sep 4, 2024 and Sep 18, 2026. Those filings report 146 transactions, from Mar 26, 2024 to Sep 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Feeley Kevin's filings is in STAMFORD, CT.
Recent filings by Feeley Kevin
- Sep 16, 2026: Open-market sales of WGS shares (3 lines, Form 4, code S).
- Sep 16, 2026: Option exercise of WGS shares (Form 4, code M).
- Sep 16, 2026: Open-market sales of WGS shares (2 lines, Form 4, code S).
- Sep 9, 2026: Open-market sale of WGS shares (Form 4, code S).
- Sep 9, 2026: Option exercise of WGS shares (Form 4, code M).
Other insiders filing for GeneDx Holdings Corp. (WGS)
- Stueland Katherine, CHIEF EXECUTIVE OFFICER
- Fuchs Thomas, Director
- GARDNER MARK A, President
- Ryan Jason, Director
- RUCH JOSHUA, Director
- PFENNIGER RICHARD C JR, Director